InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Oltmans Curtis Gale, Vice-Président Senior, Conseiller Juridique. Director active across 2 companies, notably Fulcrum Therapeutics, Inc.. Aggregated, 4 reports have been recorded. Total volume traded: €16k. The latest transaction was disclosed on 17 December 2021 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
049,020 shares0
Common Stock
SEC:0001104659-21-152195·
049,020 shares0
Common Stock
SEC:0001104659-21-152195:0·
€8,2181,088 shares@ €7.55310.0018% mcap100.0% of flow
Common Stock
SEC:0000899243-21-026556·
Ideal exit: 25 Mar 2022 (T+270)
€8,2181,088 shares@ €7.55310.0018% mcap50.0% of flow
Common Stock
SEC:0000899243-21-026556:0·
Ideal exit: 25 Mar 2022 (T+270)
4 of 4 declarations
About Oltmans Curtis Gale
Oltmans Curtis Gale serves as Senior Vice President and General Counsel at Fulcrum Therapeutics, Inc. and Avenue Therapeutics, Inc. In this role, he oversees legal and regulatory matters while contributing to the overall strategy of the company. With expertise in corporate law, he plays a key role in managing legal risks and compliance. His experience in the pharmaceutical sector allows him to provide valuable insights into the company's strategic decisions.
